Breaking
A synthetic biology-based company focused on plastic degradation, incubated at Colossal Biosciences.
Launch date
Employees
Market cap
-
Enterprise valuation
$42—63m (Dealroom.co estimates Apr 2024.)
Boston Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Corporate spinout | ||
* | N/A | $10.5m | Seed |
| Total Funding | $10.5m | ||